Nutrition

Dyadic to Report 2022 Year End Financial Results on Wednesday, March 29, 2023

JUPITER, Fla., March 15, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI),…

2 years ago

Healthy Directions Partners with Dr. Kulreet Chaudhary to Combine the Tradition Of Ayurvedic Practice with Modern-Day Science

Dr. Kulreet Chaudhary Partners with Healthy Directions Neurologist and Ayurvedic practitioner, Dr. Kulreet Chaudhary has developed Prajna Ayurveda herbals with…

2 years ago

Culture Biosciences Focuses Technology and Service Platform on Biologics

Intelligent upstream bioprocess development for therapeutics using an integrated platform of cloud-based software, single-use bioreactors, simulation tools, and process development…

2 years ago

Shiru launches OleoPro™, a protein-based alternative fat ingredient to unlock the next generation of plant-based foods

Shiru's first commercial product, OleoPro™, delivers a 90% saturated fat reduction and improved taste performance compared to current fat solutions…

2 years ago

VectivBio and Asahi Kasei Pharma Announce the Start of a Phase 1 Study of Apraglutide in Japan

Single-dose study to assess pharmacokinetics, pharmacological activity, safety and tolerability in healthy Japanese men and womenBASEL, Switzerland, March 13, 2023…

2 years ago

Yield10 Bioscience to Announce Fourth Quarter and Full Year 2022 Financial Results and Host a Conference Call on Tuesday, March 14, 2023

WOBURN, Mass., March 08, 2023 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company,…

2 years ago

Protara Therapeutics Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

- Data from Phase 1a Portion of ADVANCED-1 Trial of TARA-002 for the Treatment of Non-Muscle Invasive Bladder Cancer Expected…

2 years ago

Better Choice to Announce Fourth Quarter and Full Year 2022 Financial Results on March 28, 2023

NEW YORK, March 07, 2023 (GLOBE NEWSWIRE) -- Better Choice Company Inc. (AMEX: BTTR) (“Better Choice” or “the Company”), a…

2 years ago

Dyadic Provides Phase 1 Clinical Trial Update for its DYAI-100 COVID-19 Recombinant Protein RBD Booster Vaccine Candidate

Dosing of all patients was completed at the end of February  No Serious Adverse Events (SAE’s) have been reported  Phase 1 clinical…

2 years ago

Better Choice and Pet Supermarket Announce Partnership

Pet Supermarket will Offer Halo Brand in 75 Retail Stores in the USA Halo Products Now Offered in 1500+ Retail…

2 years ago